Back to Studies

How a new eye medicine stops TED from making eyes bulge

Original Title

The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI

Analysis v4

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

TED is when the tissue behind the eyes swells up and pushes them forward, often because the immune system gets confused and attacks the eyes. A new medicine called teprotumumab blocks a signal (IGF-1R) that makes this swelling happen.

Proposed Mechanism
TSHR-IGF-1R complex activation drives orbital fibroblast proliferation and glycosaminoglycan secretion
Verified
IGF-1R signaling promotes orbital fibroblast adipogenesis via Thy-1-negative subpopulation activation
Verified
IGF-1R signaling enhances T-cell survival and autoimmunity by inhibiting apoptosis via PI3K/Akt
Verified
IGF-1R signaling enhances B-cell proliferation and autoantibody production
Verified
TSHR activation upregulates miR-146a and miR-155 to promote fibroblast proliferation
Verified
Epac1 deficiency promotes orbital fibrosis via JAK/STAT3 pathway
Verified
Treg/Th17 imbalance permits autoimmune attack in TED
Verified
Mesenchymal stem cells inhibit orbital adipogenesis via IGF-binding protein and FAK/PI3K/Akt suppression
Verified
Rapamycin inhibits CD4+ cytotoxic T cells via mTORC1 blockade to reduce TED severity
Verified
Teprotumumab inhibits IGF-1R to reduce orbital inflammation and fibrosis
Verified

Unlock Full Mechanism Details

Sign up free to explore the biological pathways and causal mechanisms.

Quality Analysis
Methodology
1%
Lower QualityOverall Score
Narrative ReviewMedicine

Systematic Reviews & Meta-Analyses

Max 100

Randomized Controlled Trials

Max 90

Cohort Studies

Max 72

Case-Control Studies

Max 58

Cross-Sectional Studies

Max 44

Case Reports & Case Series

Max 30

Expert Opinion & Narrative Reviews

Max 5
StrongerWeaker
Expert Opinion & Narrative Reviews
Level 5
1

1 / 5

Evidence Score

Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.

Sign up free to unlock the full quality breakdown with evidence strength scoring, statistical analysis, and detailed methodology.

1%
Lower QualityOverall Score

Publication

Authors

Yuan X, Li H, Wang F

Analysis v4
DOI:10.3389/fmed.2026.1758015
View Source

Related Content